MedPath

Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)

Not Applicable
Completed
Conditions
Herpes Simplex
HIV Infections
Registration Number
NCT00002186
Lead Sponsor
Shaman Pharmaceuticals
Brief Summary

To evaluate the safety of topically applied SP-303 gel and to compare the efficacy of SP-303 gel in combination with acyclovir, relative to acyclovir alone, for the treatment of recurrent Herpes Simplex Virus (HSV) 1 and 2 infections, affecting the genital, perianal and neighboring areas, in patients with AIDS.

Detailed Description

This trial is a double-blind, multicenter, placebo-controlled clinical trial. Participants are randomized to topical 15% SP-303 gel and oral acyclovir or to matching topical placebo gel and oral acyclovir. At presentation, patients are stratified by total lesion area within each treatment group. SP-303 or matching placebo is topically applied three times a day until all lesions are reepithelialized or for 14 days, whichever occurs earlier. Acyclovir is administered by mouth each day, three times a day, until all lesions are reepithelialized or for 14 days, whichever occurs earlier. Patients are evaluated for lesion healing and adverse events 3 times per week during the treatment period. The primary efficacy endpoint will be complete lesion healing and the primary analysis will be time to complete healing.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (32)

Sorra Research Ctr Inc / Med Forum

🇺🇸

Birmingham, Alabama, United States

Hill Top Research Ltd

🇺🇸

Scottsdale, Arizona, United States

Arizona Clinical Research Ctr Inc

🇺🇸

Tucson, Arizona, United States

Dermatology SVC - VAMC

🇺🇸

Long Beach, California, United States

King - Drew Med Ctr / Dept of Dermatology

🇺🇸

Los Angeles, California, United States

Summit Med Ctr / Adult Immunology Clinic

🇺🇸

Oakland, California, United States

ViRx Inc

🇺🇸

San Francisco, California, United States

Conant Med Ctr

🇺🇸

San Francisco, California, United States

Olive View Med Ctr

🇺🇸

Sylmar, California, United States

Novum Inc

🇺🇸

Seattle, Washington, United States

Scroll for more (22 remaining)
Sorra Research Ctr Inc / Med Forum
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.